We are pleased to announce that Crypto Relief has generously funded Rs 5 crores to support COVID-19 research at the Centre for Infectious Disease Research (CIDR) at IISc. The funds will be utilised for establishing a viral genome sequencing lab, expansion of the viral BSL-3 facility, and supporting necessary manpower and consumables.
The viral genome sequencing lab, once functional, will focus on studying SARS-CoV-2, including continuous surveillance and tracking of mutants and variants. The expanded viral BSL-3 will support research on assessing the virulence and cross-reactive immunity of SARS-CoV-2 mutants and variants of concern in cell culture and animal models.
IISc’s Centre for Infectious Disease Research has been actively engaged in COVID-19 RT PCR diagnosis, in collaboration with the Government of Karnataka and Government of India. So far over 100,000 samples collected by government agencies have been tested and reported to ICMR.
The new viral genome sequencing facility will be a valuable addition to the Centre and will enhance the ongoing efforts to better understand SARS-CoV-2 virus evolution and its impact on our health.
The founder of Crypto Relief, Mr Sandeep Nailwal said, “The genome sequencing lab will play a major role in terms of understanding the COVID-19 virus and its mutations. This partnership will help the leading institute of India expand the state-of-the-art research facilities.”
